{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T14:40:36Z","timestamp":1762008036595,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":1273,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.fertnstert.2018.08.043","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T02:25:41Z","timestamp":1543544741000},"page":"1272-1273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Simvastatin and uterine fibroids: opportunity for a novel therapeutic option"],"prefix":"10.1016","volume":"110","author":[{"given":"Mohamed","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tia","family":"Jackson-Bey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Al-Hendy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2018.08.043_bib1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/17460441.2018.1417381","article-title":"Successes and failures of uterine leiomyoma drug discovery","volume":"13","author":"Ali","year":"2018","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.fertnstert.2018.08.043_bib2","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.fertnstert.2018.07.024","article-title":"Simvastatin, at clinically relevant concentrations, affects human uterine leiomyoma growth and extracellular matrix production","volume":"110","author":"Malik","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2018.08.043_bib3","doi-asserted-by":"crossref","first-page":"196.e1","DOI":"10.1016\/j.ajog.2015.03.055","article-title":"Novel effects of simvastatin on uterine fibroid tumors: in\u00a0vitro and patient-derived xenograft mouse model study","volume":"213","author":"Borahay","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2018.08.043_bib4","doi-asserted-by":"crossref","first-page":"750.e1","DOI":"10.1016\/j.ajog.2016.06.036","article-title":"Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study","volume":"215","author":"Borahay","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2018.08.043_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2125.2011.03907.x","article-title":"What is a relevant statin concentration in cell experiments claiming pleiotropic effects?","volume":"72","author":"Bj\u00f6rkhem-Bergman","year":"2011","journal-title":"Br J Clin Pharmacol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502821831882X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502821831882X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:19:38Z","timestamp":1758010778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001502821831882X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":5,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S001502821831882X"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2018.08.043","relation":{},"ISSN":["0015-0282"],"issn-type":[{"type":"print","value":"0015-0282"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simvastatin and uterine fibroids: opportunity for a novel therapeutic option","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2018.08.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2018.07.024","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a92018 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}